CATECHOLAMINES IN ATTENTION-DEFICIT HYPERACTIVITY DISORDER: CURRENT PERSPECTIVES
I tiakina i:
PLISZKA, S.R., ET AL., CATECHOLAMINES IN ATTENTION-DEFICIT HYPERACTIVITY DISORDER: CURRENT PERSPECTIVES. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, Vol. 35, no. 3 (1996), p. 264-272.
Ref.
54007
Tauwāhi:
SIIS SIIS Madrid R.598
Palabras clave:
Fármacos, Hiperactividad, Trastornos de atención, Tratamiento
Fármacos, Hiperactividad, Trastornos de atención, Tratamiento
Ngā tūemi rite: CATECHOLAMINES IN ATTENTION-DEFICIT HYPERACTIVITY DISORDER: CURRENT PERSPECTIVES
- URINARY CATECHOLAMINES IN ATTENTION-DEFICIT HYPERACTIVITY DISORDER WITH AND WITHOUT COMORBID ANXIETY
- CURRENT PRACTICE IN THE MANAGEMENT OF ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY (ADHD)
- A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ADDERALL AND METHYLPHENIDATE IN THE TREATMENT OF ATTENTION-DEFICIT / HYPERACTIVITY DISORDER
- BUPROPION HYDROCHLORIDE IN ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY
- PHARMACODYNAMICS OF PEMOLINE IN ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY
- PHARMACOTHERAPY OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER ACROSS THE LIFE CYCLE